Skip to main content
. 2018 Feb 19;17(5):557–567. doi: 10.1080/15384101.2017.1346762

Figure 6.

Figure 6.

CB002 does not reduce mutant p53 stability in SW480 and DLD-1 cells. A-B. Experiments with SW480 cells. C. Analysis of DLD-1 colorectal cancer cells. Cells were treated for a 24 hr period with DMSO, CB002 or positive control followed by 100 μg/mL cycloheximide addition, and protein stability was evaluated in a time course ranging from 0 - 10 hrs. Histone deacetylase inhibitor, SAHA and Hsp90 inhibitor Geldanamycin (1 μM GA) were used as positive controls.